P499: THE PHASE 1B OMNIVERSE TRIAL OF ORAL AZACITIDINE IN COMBINATION WITH VENETOCLAX FOR TREATMENT OF RELAPSED/REFRACTORY OR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (TRIAL IN PROGR... by A. H. Wei, H. E. Carraway, L. Taningco, E. Laille, J. Gong, T. Prebet, D. Lopes de Menezes, F. Ravandi

Get full text

PB1849: TRIAL IN PROGRESS: PHASE IB/II STUDY OF SIREMADLIN IN COMBINATION WITH VENETOCLAX + AZACITIDINE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) WHO ARE INELIGIBLE FOR INTENSI... by N. G. Daver, A. H. Wei, E. M. Stein, D. J. DeAngelo, D. Pathak, Y. Xu, S. Grzesiak, A. Venditti

Get full text

P553: A PHASE 2, OPEN-LABEL, MULTIARM, MULTICENTER STUDY TO EVALUATE MAGROLIMAB COMBINED WITH ANTILEUKEMIA THERAPIES FOR FIRST-LINE, RELAPSED/REFRACTORY, OR MAINTENANCE TREATMENT O... by P. Vyas, N. G. Daver, M. P. Chao, G. Xing, C. Renard, G. Ramsingh, A. H. Wei, D. A. Sallman

Get full text

P551: A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF MAGROLIMAB IN COMBINATION WITH AZACITIDINE IN PREVIOUSLY UNTREATED PATIENTS WITH TP53-MUTANT ACU... by N. G. Daver, P. Vyas, M. P. Chao, G. Xing, C. Renard, G. Ramsingh, D. A. Sallman, A. H. Wei

Get full text

PB1922: EFFECTIVENESS OF AZACITIDINE IN FRONTLINE HIGHER-RISK MYELODYSPLASTIC SYNDROME (HR MDS): A RETROSPECTIVE COHORT STUDY OF 382 PATIENTS by N. Rajakumaraswamy, M. Gandhi, A. H. Wei, D. A. Sallman, N. G. Daver, S. Mo, S. Iqbal, M. Chen, Y. Wang, P. Vyas

Get full text

P774: CLINICAL OUTCOMES ASSOCIATED WITH AZACITIDINE MONOTHERAPY FOR TREATMENT-NAIVE PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROME (HR MDS): A SYSTEMATIC LITERATURE REVIEW AND... by K. Hasegawa, A. H. Wei, G. Garcia-Manero, N. G. Daver, N. Rajakumaraswamy, S. Iqbal, R. J. Chan, H. Hu, P. Tse, J. Yan, M. J. Zoratti, F. Xie, D. A. Sallman

Get full text

P498: CLINICAL AND BIOLOGICAL MARKERS ASSOCIATED WITH LONG-TERM SURVIVAL FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN REMISSION AFTER CHEMOTHERAPY IN THE QUAZAR AML-001 TRIAL... by A. H. Wei, H. Döhner, H. Sayar, F. Ravandi, P. Montesinos, H. Dombret, D. Selleslag, K. Porkka, J.-H. Jang, B. Skikne, C. Beach, T. Prebet, G. Zhang, A. Risueño, M. Ugidos Guerrero, W. L. See, D. Menezes, G. J. Roboz

Get full text

P590: PRELIMINARY SAFETY AND EFFICACY OF BGB-11417, A POTENT AND SELECTIVE B-CELL LYMPHOMA 2 (BCL2) INHIBITOR, IN PATIENTS (PTS) WITH ACUTE MYELOID LEUKEMIA (AML) by J. Shortt, S. Y. Tan, P. Cannell, T. F. Ng, C. Y. Fong, S. Ramanathan, R. Rajagopal, S. Leitch, R. Gasiorowski, C. Grove, D. Lenton, P. Tan, C. DiNardo, M. T. Ling, S. Cheng, Y. Liu, M. Co, W. Y. Chan, D. Simpson, A. H. Wei

Get full text

P787: SABATOLIMAB (MBG453) COMBINATION TREATMENT REGIMENS FOR PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES: THE MYELODYSPLASTIC SYNDROMES STUDIES IN THE STIMULUS IMMUNO-MYEL... by A. M. Zeidan, A. Al-Kali, U. Borate, T. Cluzeau, A. E. DeZern, J. Esteve, A. Giagounidis, K. Kobata, R. Lyons, U. Platzbecker, D. A. Sallman, V. Santini, G. F. Sanz, M. A. Sekeres, A. H. Wei, Z. Xiao, M. Van Hoef, C. Nourry-Boulot, I. Sadek, F. Ma, A. Iordan, J. Sabo, G. Garcia-Manero

Get full text